Appendix 3X Initial Director’s Interest Notice Rule 3.19A.1 Appendix 3X Initial Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced...
Initial Director's Interest Notice - Zita Peach
Filed with ASX · · 2 pages · English
Release
Neuren Pharmaceuticals Limited on 6ix
Earlier from Neuren Pharmaceuticals
- Zita Peach to succeed Patrick Davies as Board Chair
- Q3 2026 DAYBUE net sales up 39%, full year guidance upgraded
- FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
- Trofinetide US patent protections extended to March 2041
- Pause in Trading
Later from Neuren Pharmaceuticals
- Final Director's Interest Notice - P. Davies
- Acadia enters DAYBUE STIX distribution agreement in Japan
